Xeris Pharmaceuticals Inc - Trending symbols
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Oversold | Oversold RSI (Relative Strength Index) | 2025-11-21 |
Trends
| 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Net Debt | 211,733 | -11,907 | 199,826 | 10,485 | 210,311 | -12,373 | 197,938 | -251,351 | -53,413 | |
| Income before Tax | -19,062 | 13,949 | -5,113 | -4,107 | -9,220 | 7,292 | -1,928 | 2,549 | 621 | |
| Net Income | -15,738 | 10,625 | -5,113 | -4,107 | -9,220 | 7,292 | -1,928 | 2,549 | 621 | |
| Other Stockholders Equity | 610,254 | 16,594 | 626,848 | 4,892 | 631,740 | 6,686 | 638,426 | -668,016 | -29,590 | |
| EBIT | -6,608 | -5,033 | -11,641 | 5,349 | -6,292 | -4,984 | -11,276 | 13,866 | 2,590 | |
| EBITDA | -3,349 | -5,078 | -8,427 | 5,289 | -3,138 | -5,014 | -8,152 | 13,875 | 5,723 | |
| Operating Income | -9,841 | -4,404 | -14,245 | 6,058 | -8,187 | -4,706 | -12,893 | 14,572 | 1,679 | |
| Total Other Income Expense Net | -4,538 | -3,076 | -7,614 | 3,829 | -3,785 | -643 | -4,428 | 5,032 | 604 | |
| Total Stockholder Equity | 13,641 | 16,407 | 30,048 | -16,407 | 13,641 | -9,776 | 3,865 | -10,647 | -6,782 | |
| Income Tax Expense | -408 | 69 | -339 | 0 | -339 | 1 | -338 | 10,111 | 9,773 |
Comments
How you think about this?